← back to search

Xiangyun Qiao

Fudan University · CN
Area of research
Plant Science · Cognitive Neuroscience
Research interest
Research interests include Ototoxicity, Oxidative stress, Viability assay, Rage (emotion), HMGB1, and Inflammation.
h-index
citations
67
works
3
NIH funding
primary concept
email

Recent publications

Inhibition of the HMGB1/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress
International Journal of Biological Sciences 2024cited by 42position: firstdoi
5,7-Dihydroxy-4-methylcoumarin modulates the JNK/FoxO1 signaling pathway to attenuate cisplatin-induced ototoxicity by suppressing oxidative stress and apoptosis in vitro
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2023cited by 13position: middledoi
Cinchonine and cinchonidine alleviate cisplatin‐induced ototoxicity by regulating <scp>PI3K‐AKT</scp> signaling
CNS Neuroscience & Therapeutics 2023cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yingzi He · Fudan University3 papers (2023–2024)Zhiyuan Zhang · Hunan University2 papers (2023–2023)Cai Li · Guangzhou University of Chinese Medicine2 papers (2023–2023)Huanhuan Zhu · Nanchang University2 papers (2023–2023)Wen Li · Fudan University1 papers (2024–2024)Chang Liu · Northeast Agricultural University1 papers (2024–2024)Fan Li · Nanchang University1 papers (2023–2023)Fan Li · Wenzhou Medical University1 papers (2023–2023)Xue Wang · Nanchang University1 papers (2023–2023)Xue Wang · Hebei Medical University1 papers (2023–2023)Yimeng Li · Central South University1 papers (2023–2023)Yutao Chen · University of Padua1 papers (2023–2023)Yutao Chen · Nanchang University1 papers (2023–2023)Huawei Li · Fudan University1 papers (2024–2024)Liping Zhao · Shanxi Provincial People’s Hospital1 papers (2024–2024)Jingfang Wu · Fudan University1 papers (2023–2023)Dongmei Tang · University of Electronic Science and Technology of China1 papers (2023–2023)Zhiwei Zheng · Fudan University1 papers (2024–2024)